Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort
the Dutch Pharmacology Oncology Group (DPOG), Marinda Meertens, Eline L. Giraud, Maud B.A. van der Kleij, Kim Westerdijk, Niels A.D. Guchelaar, Roos F. Bleckman, Amy Rieborn, Alex L.T. Imholz, Hans Martin Otten, Annelie Vulink, Maartje Los, Paul Hamberg, Winette T.A. van der Graaf, Hans Gelderblom, Dirk Jan A.R. Moes, K. Esther Broekman, Daan J. Touw, Stijn L.W. Koolen, Ron H.J. MathijssenAlwin D.R. Huitema, Nielka P. van Erp, Ingrid M.E. Desar, Neeltje Steeghs*
Research output: Contribution to journal › Article › Academic › peer-review
44Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort'. Together they form a unique fingerprint.